Atlas Trials

Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT03764605 · UNKNOWN

Trial details

NCT number
NCT03764605
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
ADPKD
Start date
2019-01-30
Primary completion
2021-09-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.